Peptides of China — our platform for china peptides sourcing — publishes short updates like this one whenever something material changes: catalog additions, quality-process notes, and sourcing announcements. The substance of this update is below.
Most high-demand compounds are now back in stock, including AICAR, Hexarelin, MGF, Sermorelin, Survodutide, and additional research products. Learn why we continue using our deposit and reservation system to ensure reliable order fulfillment.
We are pleased to announce that most products are now back in stock, including high-demand compounds such as AICAR, GHRH-6, Hexarelin, MGF, Sermorelin, Survodutide, and many others.
To improve supply stability, we are actively working to maintain a minimum reserve of at least 30 kits per product whenever possible. However, it is important to understand that a significant portion of our customer base consists of companies purchasing products for private-label and resale operations.
Because of this, situations occasionally occur where a single client may purchase the entire available inventory of a specific compound within a short period of time.
For this reason, we continue to operate using our current
• Initial deposit • Real-time stock confirmation • Order reservation prior to final payment
This process allows us to verify current manufacturer-side availability and helps ensure reliable order fulfillment for all clients.
We appreciate your understanding and continued trust in Peptides of China.
China Peptides Sourcing Perspective
For catalog listings, batch specifications, and ordering information, see the catalog or how sourcing works.